Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gallium-68 PSMA-11 PET in Biochemical Recurrence
NCT03396874Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Feb 2018
- Primary completion
- Aug 2022
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by University of Michigan. Started Feb 2018; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03396874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396874.